Literature DB >> 19501188

Subcellular localization of ceramide kinase and ceramide kinase-like protein requires interplay of their Pleckstrin Homology domain-containing N-terminal regions together with C-terminal domains.

Philipp Rovina1, Andrea Schanzer, Christine Graf, Diana Mechtcheriakova, Markus Jaritz, Frédéric Bornancin.   

Abstract

Ceramide kinase (CERK) and the ceramide kinase-like protein (CERKL), two related members of the diacylglycerol kinase family, are ill-defined at the molecular level. In particular, what determines their distinctive subcellular localization is not well understood. Here we show that the Pleckstrin Homology (PH) domain of CERK, which is required for Golgi complex localization, can substitute for the N-terminal region of CERKL and allow for wild-type CERKL localization, which is typified by nucleolar accumulation. This demonstrates that determinants for localization of these two enzymes do not lie solely in their PH domain-containing N-terminal regions. Moreover, we present evidence for a previously unrecognized participation of CERK distal sequences in structural stability, localization and activity of the full-length protein. Progressive deletion of CERK and CERKL from the C-terminus revealed similar sequential organization in both proteins, with nuclear import signals in their N-terminal part, and nuclear export signals in their C-terminal part. Furthermore, mutagenesis of individual cysteine residues of a CERK-specific CXXXCXXC motif severely compromised both exportation of CERK from the nucleus and its association with the Golgi complex. Altogether, this work identifies conserved domains in CERK and CERKL as well as new determinants for their subcellular localization. It further suggests a nucleocytoplasmic shuttling mechanism for both proteins that may be defective in CERKL mutant proteins responsible for retinal degenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19501188     DOI: 10.1016/j.bbalip.2009.05.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  23 in total

Review 1.  Evolving concepts in cancer therapy through targeting sphingolipid metabolism.

Authors:  Jean-Philip Truman; Mónica García-Barros; Lina M Obeid; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2013-12-30

2.  The ATP-binding cassette transporter-2 (ABCA2) regulates esterification of plasma membrane cholesterol by modulation of sphingolipid metabolism.

Authors:  Warren Davis
Journal:  Biochim Biophys Acta       Date:  2013-11-05

Review 3.  Nuclear sphingolipid metabolism.

Authors:  Natasha C Lucki; Marion B Sewer
Journal:  Annu Rev Physiol       Date:  2011-09-09       Impact factor: 19.318

4.  Loss of ceramide kinase in Arabidopsis impairs defenses and promotes ceramide accumulation and mitochondrial H2O2 bursts.

Authors:  Fang-Cheng Bi; Zhe Liu; Jian-Xin Wu; Hua Liang; Xue-Li Xi; Ce Fang; Tie-Jun Sun; Jian Yin; Guang-Yi Dai; Chan Rong; Jean T Greenberg; Wei-Wei Su; Nan Yao
Journal:  Plant Cell       Date:  2014-08-22       Impact factor: 11.277

5.  Expression and localization of CERKL in the mammalian retina, its response to light-stress, and relationship with NeuroD1 gene.

Authors:  Nawajes A Mandal; Julie-Thu A Tran; Anisse Saadi; Abul K Rahman; Tuan-Phat Huynh; William H Klein; Jang-Hyeon Cho
Journal:  Exp Eye Res       Date:  2012-11-08       Impact factor: 3.467

6.  The ceramide kinase inhibitor NVP-231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell death.

Authors:  Oleksandr Pastukhov; Stephanie Schwalm; Uwe Zangemeister-Wittke; Doriano Fabbro; Frederic Bornancin; Lukasz Japtok; Burkhard Kleuser; Josef Pfeilschifter; Andrea Huwiler
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

Review 7.  Nuclear Lipids in the Nervous System: What they do in Health and Disease.

Authors:  Mercedes Garcia-Gil; Elisabetta Albi
Journal:  Neurochem Res       Date:  2016-10-20       Impact factor: 3.996

8.  Identification of an acid sphingomyelinase ceramide kinase pathway in the regulation of the chemokine CCL5.

Authors:  Benjamin Newcomb; Cosima Rhein; Izolda Mileva; Rasheed Ahmad; Christopher J Clarke; Justin Snider; Lina M Obeid; Yusuf A Hannun
Journal:  J Lipid Res       Date:  2018-05-03       Impact factor: 5.922

Review 9.  Ceramide and ceramide 1-phosphate in health and disease.

Authors:  Lide Arana; Patricia Gangoiti; Alberto Ouro; Miguel Trueba; Antonio Gómez-Muñoz
Journal:  Lipids Health Dis       Date:  2010-02-05       Impact factor: 3.876

Review 10.  Nuclear lipid mediators: Role of nuclear sphingolipids and sphingosine-1-phosphate signaling in epigenetic regulation of inflammation and gene expression.

Authors:  Panfeng Fu; David L Ebenezer; Alison W Ha; Vidyani Suryadevara; Anantha Harijith; Viswanathan Natarajan
Journal:  J Cell Biochem       Date:  2018-05-08       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.